Considering the proposed model of BCP-ALL development [14, 15], our data support the notion that pre-BCR+ ALL are arrested at the pre-B cell stage, e.g. most TCF3-PBX1. The gene discussed is TCF3; the disease is acute lymphoblastic leukemia.